Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 138 | $77,751,392 |
| Sells | 184 | $100,301,247 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 08 Nov 2024 17:07 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 07 Nov 2024 | Sale | 5,000 | 350 | 1,750,000 | D |
| 05 Nov 2024 19:01 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Nov 2024 | Sale | 2,800 | 300.0993 | 840,278 | D |
| 05 Nov 2024 19:01 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Nov 2024 | Sale | 1,100 | 301.2173 | 331,339 | D |
| 05 Nov 2024 19:01 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Nov 2024 | Sale | 800 | 302.2488 | 241,799 | D |
| 05 Nov 2024 19:01 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Nov 2024 | Sale | 300 | 304.291 | 91,287 | D |
| 11 Sep 2024 21:51 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SIBOLD WILLIAM JOHN | President and CEO | 09 Sep 2024 | Sale | 6,363 | 243.83 | 1,551,490 | D |
| 18 Jun 2024 21:39 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 14 Jun 2024 | Sale | 1,900 | 280 | 532,000 | D |
| 14 Jun 2024 21:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 12 Jun 2024 | Sale | 2,000 | 285 | 570,000 | D |
| 23 May 2024 21:36 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 21 May 2024 | Sale | 1,036 | 231.34 | 239,668 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 1,000 | 218.9945 | 218,994 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 100 | 219.9 | 21,990 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 1,100 | 217.8553 | 239,641 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 721 | 216.9838 | 156,445 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 1,804 | 214.6815 | 387,285 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 375 | 216.0836 | 81,031 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 2,190 | 213.8548 | 468,342 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 1,363 | 212.8513 | 290,116 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 5,009 | 211.844 | 1,061,127 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 8,827 | 210.9926 | 1,862,432 | D |
| 10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 200 | 248.58 | 49,716 | D |
| 10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 407 | 247.7582 | 100,838 | D |
| 10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 600 | 246.9773 | 148,186 | D |
| 10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 945 | 244.7881 | 231,325 | D |
| 10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 300 | 245.6867 | 73,706 | D |
| 10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 224 | 243.245 | 54,487 | D |
| 10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 4,866 | 248.5907 | 1,209,642 | D |
| 10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 5,028 | 246.959 | 1,241,710 | D |
| 10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 3,464 | 247.7601 | 858,241 | D |
| 10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 2,078 | 245.7126 | 510,591 | D |
| 10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 5,663 | 244.8607 | 1,386,646 | D |
| 10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 3,730 | 244.1197 | 910,566 | D |
| 10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 1,441 | 242.9523 | 350,094 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 5,278 | 245.5332 | 1,295,924 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 2,079 | 244.4509 | 508,213 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 8,817 | 242.6073 | 2,139,069 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 8,989 | 243.3294 | 2,187,288 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 700 | 241.1413 | 168,799 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 1,643 | 240.1076 | 394,497 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 100 | 248.23 | 24,823 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 711 | 247.2268 | 175,778 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 1,653 | 246.0123 | 406,658 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 435 | 244.0066 | 106,143 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 2,734 | 245.0643 | 670,006 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 3,085 | 242.7114 | 748,765 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 5,619 | 241.8528 | 1,358,971 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 4,200 | 240.8759 | 1,011,679 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 03 Apr 2024 | Sale | 2,089 | 246.3249 | 514,573 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 03 Apr 2024 | Sale | 18,917 | 245.3356 | 4,641,014 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 03 Apr 2024 | Sale | 4,070 | 244.6815 | 995,854 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 03 Apr 2024 | Sale | 2,634 | 243.6849 | 641,866 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 03 Apr 2024 | Sale | 135 | 242 | 32,670 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 05 Apr 2024 | Sale | 444 | 245.9221 | 109,189 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 05 Apr 2024 | Sale | 5,228 | 245.346 | 1,282,669 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 05 Apr 2024 | Sale | 3,966 | 244.2228 | 968,588 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 05 Apr 2024 | Sale | 9,264 | 243.2012 | 2,253,016 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 05 Apr 2024 | Sale | 612 | 241.1478 | 147,582 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 05 Apr 2024 | Sale | 6,679 | 242.4162 | 1,619,098 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 05 Apr 2024 | Sale | 1,420 | 240.0979 | 340,939 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 200 | 248.425 | 49,685 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 737 | 247.1385 | 182,141 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 1,558 | 246.1302 | 383,471 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 2,549 | 245.1381 | 624,857 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 627 | 244.3138 | 153,185 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 5,299 | 242.2492 | 1,283,679 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 1,467 | 243.0005 | 356,482 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 6,273 | 241.0684 | 1,512,222 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 03 Apr 2024 | Sale | 1,821 | 246.3097 | 448,530 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 03 Apr 2024 | Sale | 18,806 | 245.3378 | 4,613,823 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 03 Apr 2024 | Sale | 4,301 | 244.5847 | 1,051,959 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 03 Apr 2024 | Sale | 2,294 | 243.6447 | 558,921 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 03 Apr 2024 | Sale | 185 | 242 | 44,770 | D |
| 03 Apr 2024 20:47 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Apr 2024 | Sale | 300 | 267.0733 | 80,122 | D |
| 03 Apr 2024 20:47 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Apr 2024 | Sale | 713 | 265.2809 | 189,145 | D |
| 03 Apr 2024 20:47 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Apr 2024 | Sale | 100 | 259.07 | 25,907 | D |
| 03 Apr 2024 20:47 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Apr 2024 | Sale | 1,600 | 257.9347 | 412,696 | D |
| 03 Apr 2024 20:47 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Apr 2024 | Sale | 4,387 | 255.899 | 1,122,629 | D |
| 03 Apr 2024 20:47 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Apr 2024 | Sale | 3,900 | 256.881 | 1,001,836 | D |
| 03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 7 | 249.05 | 1,743 | D |
| 03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 193 | 248.4887 | 47,958 | D |
| 03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 100 | 246.8805 | 24,688 | D |
| 03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 567 | 246.2028 | 139,597 | D |
| 03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 7,048 | 244.2722 | 1,721,630 | D |
| 03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 2,080 | 244.965 | 509,527 | D |
| 03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 1,217 | 243.2823 | 296,075 | D |
| 03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 274 | 266.9052 | 73,132 | D |
| 03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 700 | 265.3557 | 185,749 | D |
| 03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 116 | 264.7343 | 30,709 | D |
| 03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 143 | 263.0816 | 37,621 | D |
| 03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 200 | 259.13 | 51,826 | D |
| 03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 841 | 262.1797 | 220,493 | D |
| 03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 2,104 | 258.2412 | 543,339 | D |
| 03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 2,790 | 257.3262 | 717,940 | D |
| 03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 7,411 | 256.4904 | 1,900,850 | D |
| 03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 6,698 | 255.6165 | 1,712,119 | D |
| 03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 02 Apr 2024 | Sale | 200 | 248.4508 | 49,690 | D |
| 03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 02 Apr 2024 | Sale | 43 | 247.0342 | 10,622 | D |
| 03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 02 Apr 2024 | Sale | 557 | 246.2958 | 137,187 | D |
| 03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 02 Apr 2024 | Sale | 2,991 | 244.8946 | 732,480 | D |
| 03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 02 Apr 2024 | Sale | 6,279 | 244.1927 | 1,533,286 | D |
| 03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 02 Apr 2024 | Sale | 842 | 243.2559 | 204,821 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)